Diseases Home > Benlysta for Lupus

The prescription drug Benlysta® (belimumab) is designed for use in combination with other standard lupus treatments. It is approved for the treatment of systemic lupus erythematosus, the most common form of lupus. Benlysta comes in the form of an intravenous infusion. Each dose is slowly given through an IV over the course of an hour.
This medication has not been studied adequately in people with severe lupus affecting the kidneys (severe active lupus nephritis) or severe lupus that affects the brain or spinal cord (severe active central nervous system lupus). Therefore, it is not approved to treat these conditions.
(To learn more about this lupus medication, click Benlysta Uses. This article takes an in-depth look at how it works, who can use it, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.